Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 12, 2023

BUY
$32.86 - $55.7 $315,456 - $534,720
9,600 New
9,600 $366,000
Q3 2022

Nov 14, 2022

BUY
$38.53 - $51.78 $735,923 - $988,998
19,100 New
19,100 $755,000

Others Institutions Holding HALO

About HALOZYME THERAPEUTICS, INC.


  • Ticker HALO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 139,288,992
  • Market Cap $6.62B
  • Description
  • Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...
More about HALO
Track This Portfolio

Track Boulder Hill Capital Management LP Portfolio

Follow Boulder Hill Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Boulder Hill Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Boulder Hill Capital Management LP with notifications on news.